Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
Article in International Journal of Molecular Sciences (July 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression
Article in Molecular Therapy (April 2024)
Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors
Article in International Journal of Molecular Sciences (January 2024)